Type of security: Stock
Sector: Health Care
Industry: Industrial Specialties
Market Capitalization: 22.66 B
The data is delayed by 15 minutes.
EW is in the long-term up 116% in 5 years.
Description: Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products, which are used to replace or repair a patient?s diseased or defective heart valve; and produces pericardial valves from biologically inert animal tissue. Its surgical heart valve therapy products include Carpentier-Edwards PERIMOUNT pericardial valve that comprise PERIMOUNT Magna Ease valves for aortic and mitral replacement; ThruPort systems that enable minimal incision valve surgery; and protection cannulae that is used during cardiac surgery in venous drainage, aortic perfusion, venting, and cardioplegia delivery. The company also provides transcatheter heart valves portfolio that includes technologies designed to treat heart valve disease using catheter-based approaches, as well as critical care products, such as hemodynamic monitoring systems to measure a patie
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||211.76 M||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||1.55%||Sales Growth - Q/Q||4.49%||P/E|
|P/E To EPS Growth||P/S||9.32||P/BV||9.9||Price/Cash Per Share||16.09|
|Price/Free Cash Flow||24.13||ROA||12.19%||ROE||19.22%||ROI||13.91%|
|Current Ratio||5.16||Quick Ratio||4.46||Long Term Debt/Equity||0.32||Debt Ratio||0.19|
|Gross Margin||74.38%||Operating Margin||23.69%||Net Profit Margin||18.08%||Dividend Payout Ratio|
|Cash From Financing Activities||-122.5 M||Cash From Investing Activities||-167.8 M||Cash From Operating Activities||243.4 M||Gross Profit||458.2 M|
|Net Profit||112.7 M||Operating Profit||142.2 M||Total Assets||3.61 B||Total Current Assets||2.3 B|
|Total Current Liabilities||445.2 M||Total Debt||600.3 M||Total Liabilities||1.32 B||Total Revenue||616.8 M|
|High 52 week||192.15||Low 52 week||134.83||Last close||173.12||Last change||-2.27%|
|RSI||47.88||Average true range||4.13||Beta||0.63||Volume||1.17 M|
|Simple moving average 20 days||-2.81%||Simple moving average 50 days||-5.36%||Simple moving average 200 days||7.08%|
|Performance Week||-4.41%||Performance Month||-2.46%||Performance Quart||-2.62%||Performance Half||16.78%|
|Performance Year||26.9%||Performance Year-to-date||13.02%||Volatility daily||1.28%||Volatility weekly||2.87%|
|Volatility monthly||5.87%||Volatility yearly||20.35%||Relative Volume||162.97%||Average Volume||1.3 M|
|New High||New Low|
2020-06-04 16:38:05 | Thursday Morning Market Highlights
2020-05-29 11:08:30 | Hedge Funds Have Never Been This Bullish On Edwards Lifesciences Corporation EW
2020-05-26 13:38:44 | Frank Sands Adds 5 Stocks to Portfolio
2020-05-26 08:39:12 | Here's Why You Should Hold on to Edwards Lifesciences for Now
2020-05-23 11:30:03 | Edwards Lifesciences EW Down 1% Since Last Earnings Report: Can It Rebound?
2020-05-18 13:07:00 | Wedgewood Partners Cuts Fastenal, Alphabet, Visa
2020-05-11 12:53:21 | Is Edwards Lifesciences EW a Great Value Stock Right Now?
2020-05-07 16:15:00 | Edwards Announces Updates From Annual Meeting
2020-05-06 18:24:00 | Stock Upgrades: Edwards Lifesciences Shows Rising Relative Strength
2020-05-05 08:15:00 | Edwards Lifesciences Announces May 2020 Investor Conference Schedule
2020-05-04 23:44:11 | Edited Transcript of EW earnings conference call or presentation 23-Apr-20 9:00pm GMT
2020-05-04 12:07:00 | Why Edwards Lifesciences Shares Rose 15.3% in April
2020-05-04 10:53:44 | Were Hedge Funds Right About Edwards Lifesciences Corporation EW?
2020-04-30 09:27:56 | Why Wedgewood Partners is Bullish on Edwards Lifesciences EW Stock?
2020-04-29 13:21:05 | Top Stock Research Reports for Cisco, Abbott, NextEra & Others
2020-04-28 07:54:08 | Benzinga Pro's Top 4 Stocks To Watch For Tues., Apr. 28, 2020: BA, FFIV, EW, ATIF
2020-04-24 11:12:03 | The Zacks Analyst Blog Highlights: Intel and Edwards Lifesciences
2020-04-24 10:39:02 | Edwards Lifesciences EW Beats on Q1 Earnings, Cuts '20 View
2020-04-23 18:05:10 | Intel, Edwards Lifesciences Top Q1 Earnings Estimates
2020-04-23 17:45:09 | Edwards Lifesciences EW Q1 Earnings and Revenues Top Estimates
2020-04-23 17:25:03 | Medical Giant Calls For Coronavirus Hit In 2020; But Shares Eye Breakout
2020-04-23 16:15:00 | Edwards Lifesciences Reports First Quarter Results
2020-04-23 15:00:00 | Edwards Lifesciences Corp. to Host Earnings Call
2020-04-22 15:36:19 | How the $484B stimulus bill will impact the healthcare sector
2020-04-20 09:55:01 | Can TAVR's SAPIEN 3 Aid Edwards Lifesciences EW Q1 Earnings?
2020-04-16 17:50:09 | Edwards Lifesciences EW Outpaces Stock Market Gains: What You Should Know
2020-04-16 12:31:04 | Edwards Lifesciences EW Earnings Expected to Grow: Should You Buy?
2020-04-13 16:30:00 | Edwards Lifesciences To Hold Virtual Annual Meeting Of Stockholders
2020-04-09 10:05:00 | Edwards Lifesciences To Host Earnings Conference Call On April 23, 2020
2020-04-07 17:50:09 | Edwards Lifesciences EW Dips More Than Broader Markets: What You Should Know
2020-03-29 09:00:00 | Edwards SAPIEN 3 Valve Shows Excellent Results At 2 Years
2020-03-27 05:49:09 | Bull of the Day: Edwards Lifesciences EW
2020-03-25 16:06:43 | Industries That Thrive During Recessions
2020-03-25 14:00:00 | Heart Device Maker Edwards Lifesciences Stock Pumps Up Amid Coronavirus Outbreak
2020-03-19 15:38:59 | 6 Med-Tech and Medical-Device Stocks to Buy
2020-03-19 14:04:23 | Edwards Lifesciences: A Leader in an Economically Attractive and Rapidly Growing Niche
2020-03-13 08:05:30 | What Does Edwards Lifesciences Corporation's NYSE:EW Share Price Indicate?
2020-03-12 11:04:10 | Is Edwards Lifesciences Corporation EW A Good Stock To Buy?
2020-03-03 15:00:00 | Edwards Lifesciences Shows Improved Price Strength & IBD Rating Upgrade
2020-03-02 08:46:01 | Medtronic Demonstrates All-Line Growth Despite Cost Concerns